↓ Skip to main content

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

Overview of attention for article published in Health and Quality of Life Outcomes, October 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
1 policy source
patent
3 patents

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
Published in
Health and Quality of Life Outcomes, October 2006
DOI 10.1186/1477-7525-4-80
Pubmed ID
Authors

Kristina Secnik Boye, Louis S Matza, Alan Oglesby, Karen Malley, Sunny Kim, Risa P Hayes, Robert Brodows

Abstract

Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several differences between the two treatments that could influence outcomes from the patient's perspective. The purpose of the current study was to examine whether the two drugs were comparable as assessed by patient-reported outcomes using data from a clinical trial in which these injectable medications were added to pre-existing oral treatment regimens.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Brazil 1 1%
Unknown 77 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 22%
Researcher 11 14%
Student > Ph. D. Student 10 13%
Other 9 11%
Student > Bachelor 6 8%
Other 12 15%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 27 34%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Psychology 6 8%
Agricultural and Biological Sciences 6 8%
Nursing and Health Professions 5 6%
Other 14 18%
Unknown 15 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2021.
All research outputs
#3,293,687
of 22,919,505 outputs
Outputs from Health and Quality of Life Outcomes
#292
of 2,168 outputs
Outputs of similar age
#7,236
of 66,421 outputs
Outputs of similar age from Health and Quality of Life Outcomes
#2
of 11 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,168 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,421 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.